2025 Q4 -tulosraportti
Vain PDF
49 päivää sitten
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 478 | - | - | ||
| 50 000 | - | - | ||
| 55 556 | - | - | ||
| 13 000 | - | - | ||
| 2 000 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 4 987 118 | 4 987 118 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 4 987 118 | 4 987 118 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 25.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 6.2. | ||
2025 Q3 -tulosraportti 24.10.2025 | ||
2025 Q2 -tulosraportti 11.7.2025 | ||
2025 Q1 -tulosraportti 10.4.2025 | ||
2024 Q4 -tulosraportti 5.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·17.3.sold off 6 million shares in a couple of days, looks like a knowledgeable CEO and Batljan is insanely fun to build up nisse but bad at managing, so it's important to exit in time. target price +40 öre then I'm out 80%
22.3.22.3.Tämä kommentti on poistettu.
·12.3.Together with major shareholder Ilija Batljan, Episurf's newly appointed CEO has his sights set on creating a new large real estate company. For Fastighetsnytt, Jens Andersson talks about the cash flow hunt, how to acquire industry colleagues and why specialization is completely the wrong way to go. ✓The aggressive plan: The critical size to be reached within two years ✓ This is what the billion-journey looks like: The properties, the financing and the path to an IG-rating ✓Sven-Olof Johansson's mazariners ✓Next step: Expansion abroad ✓The future of the medtech division Read more on fastighetsnytt
·10.3.What do you think will happen next?
·10.3.It is not possible to like something that has not occurred.
·3.3.CEO buys for 5 million? Not bad. I'll have a thousand-pack too. Probably a better chance to win with this company than with a couple of Trisslotter anyway.
·3.3.Episurf Medical B (EPIS B) is currently undergoing a significant transformation. Here is a summary of the most important news and outlook based on the latest reports from early 2026: Latest news (Q4 2025 and 2026) • Strategic change: During 2025, the company has implemented a comprehensive shift by combining its medical business with the acquisition of real estate assets. This has led to Torvinge Fastigheter becoming a new major owner with 7.8 % of the capital. • Financial improvement: In the annual report for 2025, the company reported increased order intake (up 13 % in Q4) and increased revenues, while operating costs were significantly reduced compared to the previous year. • Management changes: Episurf announced a new CEO in January 2026, with further management changes taking effect on February 11, 2026. • Capital changes: The number of shares has increased sharply after the exercise of subscription options (series TO14 B) and directed issues in February 2026, which has provided the company with new capital. Future outlook • USA market: The company has recently received patent approval in the USA for its Episealer® MTP implant (big toe), which provides protection in the American market. Commercial launch of this implant in the USA has taken longer than expected, but is a key driver for future growth. • Product range: The focus going forward is on commercialization of the Episealer® Patellofemoral System (kneecap), which has already received FDA approval. • Analyst assessment: The analysis firm Redeye has previously adjusted down its estimates due to restructuring in Europe, but now sees signs of stabilization through cost cuts and a new strategy. • Technical analysis: The stock has broken a falling trend channel, which may indicate a weaker rate of decline or bottom formation, with support around 0.03 SEK.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
49 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·17.3.sold off 6 million shares in a couple of days, looks like a knowledgeable CEO and Batljan is insanely fun to build up nisse but bad at managing, so it's important to exit in time. target price +40 öre then I'm out 80%22.3.22.3.Tämä kommentti on poistettu.
- ·12.3.Together with major shareholder Ilija Batljan, Episurf's newly appointed CEO has his sights set on creating a new large real estate company. For Fastighetsnytt, Jens Andersson talks about the cash flow hunt, how to acquire industry colleagues and why specialization is completely the wrong way to go. ✓The aggressive plan: The critical size to be reached within two years ✓ This is what the billion-journey looks like: The properties, the financing and the path to an IG-rating ✓Sven-Olof Johansson's mazariners ✓Next step: Expansion abroad ✓The future of the medtech division Read more on fastighetsnytt
- ·10.3.What do you think will happen next?·10.3.It is not possible to like something that has not occurred.
- ·3.3.CEO buys for 5 million? Not bad. I'll have a thousand-pack too. Probably a better chance to win with this company than with a couple of Trisslotter anyway.
- ·3.3.Episurf Medical B (EPIS B) is currently undergoing a significant transformation. Here is a summary of the most important news and outlook based on the latest reports from early 2026: Latest news (Q4 2025 and 2026) • Strategic change: During 2025, the company has implemented a comprehensive shift by combining its medical business with the acquisition of real estate assets. This has led to Torvinge Fastigheter becoming a new major owner with 7.8 % of the capital. • Financial improvement: In the annual report for 2025, the company reported increased order intake (up 13 % in Q4) and increased revenues, while operating costs were significantly reduced compared to the previous year. • Management changes: Episurf announced a new CEO in January 2026, with further management changes taking effect on February 11, 2026. • Capital changes: The number of shares has increased sharply after the exercise of subscription options (series TO14 B) and directed issues in February 2026, which has provided the company with new capital. Future outlook • USA market: The company has recently received patent approval in the USA for its Episealer® MTP implant (big toe), which provides protection in the American market. Commercial launch of this implant in the USA has taken longer than expected, but is a key driver for future growth. • Product range: The focus going forward is on commercialization of the Episealer® Patellofemoral System (kneecap), which has already received FDA approval. • Analyst assessment: The analysis firm Redeye has previously adjusted down its estimates due to restructuring in Europe, but now sees signs of stabilization through cost cuts and a new strategy. • Technical analysis: The stock has broken a falling trend channel, which may indicate a weaker rate of decline or bottom formation, with support around 0.03 SEK.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 478 | - | - | ||
| 50 000 | - | - | ||
| 55 556 | - | - | ||
| 13 000 | - | - | ||
| 2 000 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 4 987 118 | 4 987 118 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 4 987 118 | 4 987 118 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 25.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 6.2. | ||
2025 Q3 -tulosraportti 24.10.2025 | ||
2025 Q2 -tulosraportti 11.7.2025 | ||
2025 Q1 -tulosraportti 10.4.2025 | ||
2024 Q4 -tulosraportti 5.2.2025 |
2025 Q4 -tulosraportti
Vain PDF
49 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 25.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 6.2. | ||
2025 Q3 -tulosraportti 24.10.2025 | ||
2025 Q2 -tulosraportti 11.7.2025 | ||
2025 Q1 -tulosraportti 10.4.2025 | ||
2024 Q4 -tulosraportti 5.2.2025 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·17.3.sold off 6 million shares in a couple of days, looks like a knowledgeable CEO and Batljan is insanely fun to build up nisse but bad at managing, so it's important to exit in time. target price +40 öre then I'm out 80%22.3.22.3.Tämä kommentti on poistettu.
- ·12.3.Together with major shareholder Ilija Batljan, Episurf's newly appointed CEO has his sights set on creating a new large real estate company. For Fastighetsnytt, Jens Andersson talks about the cash flow hunt, how to acquire industry colleagues and why specialization is completely the wrong way to go. ✓The aggressive plan: The critical size to be reached within two years ✓ This is what the billion-journey looks like: The properties, the financing and the path to an IG-rating ✓Sven-Olof Johansson's mazariners ✓Next step: Expansion abroad ✓The future of the medtech division Read more on fastighetsnytt
- ·10.3.What do you think will happen next?·10.3.It is not possible to like something that has not occurred.
- ·3.3.CEO buys for 5 million? Not bad. I'll have a thousand-pack too. Probably a better chance to win with this company than with a couple of Trisslotter anyway.
- ·3.3.Episurf Medical B (EPIS B) is currently undergoing a significant transformation. Here is a summary of the most important news and outlook based on the latest reports from early 2026: Latest news (Q4 2025 and 2026) • Strategic change: During 2025, the company has implemented a comprehensive shift by combining its medical business with the acquisition of real estate assets. This has led to Torvinge Fastigheter becoming a new major owner with 7.8 % of the capital. • Financial improvement: In the annual report for 2025, the company reported increased order intake (up 13 % in Q4) and increased revenues, while operating costs were significantly reduced compared to the previous year. • Management changes: Episurf announced a new CEO in January 2026, with further management changes taking effect on February 11, 2026. • Capital changes: The number of shares has increased sharply after the exercise of subscription options (series TO14 B) and directed issues in February 2026, which has provided the company with new capital. Future outlook • USA market: The company has recently received patent approval in the USA for its Episealer® MTP implant (big toe), which provides protection in the American market. Commercial launch of this implant in the USA has taken longer than expected, but is a key driver for future growth. • Product range: The focus going forward is on commercialization of the Episealer® Patellofemoral System (kneecap), which has already received FDA approval. • Analyst assessment: The analysis firm Redeye has previously adjusted down its estimates due to restructuring in Europe, but now sees signs of stabilization through cost cuts and a new strategy. • Technical analysis: The stock has broken a falling trend channel, which may indicate a weaker rate of decline or bottom formation, with support around 0.03 SEK.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 478 | - | - | ||
| 50 000 | - | - | ||
| 55 556 | - | - | ||
| 13 000 | - | - | ||
| 2 000 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 4 987 118 | 4 987 118 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 4 987 118 | 4 987 118 | 0 | 0 |